New type of dual-acting antibiotic shows promise

A new antibiotic hits germs with a two pronged attack.

New type of dual-acting antibiotic shows promise
Credit: fizkes / Adobe Stock
  • Antibiotic resistance is a big problem, but not many new drugs are currently under development.
  • A recent discovery may give us a new antibiotic that is effective against a wide range of germs, including those resistant to other drugs.
  • The new drug's mechanism also appears to signal the immune system, helping to amplify its response.

Antibiotic resistance is a major problem, but one that seems to bother academics and specialists more than it worries members of the general public. Years of intemperate and often outright irresponsible antibiotic usage has given many formally treatable diseases more chances to evolve immunity to first-line drugs. In some cases, terrible diseases are increasingly resistant to a wide variety of medications.

These bacteria have evolved various techniques for surviving exposure to antibiotics, including growing stronger cell walls to keep drugs out, producing enzymes that neutralize them, and even little pumps that remove them when they do get in.

This is concerning, as not only are these diseases challenging to treat, but research into new antibiotics is limited. There aren't that many new drugs in development. However, a new study published in Nature suggests that a new line of synthetic drugs might be able to rev up the immune system and attack bacteria in a powerful new way.

The delicate art of carpet bombing bacteria

The trick with finding any antibiotic is to identify a substance that can damage bacterial cells without also harming the cells of the animal they are making sick. This is a relatively simple concept, but a difficult problem to get around.

Researchers at the Wistar Institute dealt with it by selecting something unique to bacteria, which was important in their functioning to focus on, and then finding chemicals that would disrupt it. They chose a metabolic pathway, known as the non-mevalonate pathway, which is used to create molecules necessary for the bacteria cell to survive. They then selected an enzyme in this pathway, the IspH enzyme, to target specifically.

Using computer models, the researchers screened several million existing compounds and substances to determine which ones would bind to IspH and then began experiments with the most promising candidates. A new, synthetic IspH inhibitor was created as a result of this.

How it works

The molecules that IspH helps to make are required in bacteria for respiration and repairing the cell wall. When this new antibiotic attaches to them and keeps them from doing their job, the cell either dies because it can't breathe or keep its insides in, or it stays alive but is unable to function normally. Both of these methods are commonly seen in other antibiotics. By either killing off the germs or slowing them down, they give the immune system time to step up and keep the infection under control.

The antibiotic was also found to amplify the response of the immune system. In tests involving mice, Gamma Delta T-cells, an important part of the immune system, activated at higher rates, often leading to better outcomes. This effect appears to be caused by the disruption to the bacteria; their impaired function caused them to signal themselves to the immune system.

This gives the new drug a dual function, which is hypothesized to not only make it quite effective but also may help prevent bacteria from developing resistance to it. It is thought that bacteria being hit from both directions are less likely to mutate responses to both.

IspH is a common enzyme in bacteria. Unlike some antibiotics, which are effective only against a narrow range of similar germs, this one may prove effective against a wide variety of microbes includes ones that are resistant to other drugs.

The researchers are, justly, proud of their discovery. Farokh Dotiwala, the study's lead author, suggested the finding may be more than just the discovery of a new drug in a press release:

"We believe this innovative DAIA strategy may represent a potential landmark in the world's fight against AMR, creating a synergy between the direct killing ability of antibiotics and the natural power of the immune system."

So, I presume I can get this tomorrow?

Not quite. This was an initial study conducted in mice, various kinds of plasma, and in test tubes.

While the results were promising, it will take some time before further studies are conducted and the drug becomes widely available. Additionally, while the study suggests the new drugs may be more effective against certain kinds of bacteria than existing antibiotics, exactly how well it works in humans remains to be seen.

Beyond that, if it is used as a front line drug or as a last resort is still to be determined. Future circumstances, dictated by what diseases we'll face, will likely answer that question.

‘Designer baby’ book trilogy explores the moral dilemmas humans may soon create

How would the ability to genetically customize children change society? Sci-fi author Eugene Clark explores the future on our horizon in Volume I of the "Genetic Pressure" series.

Surprising Science
  • A new sci-fi book series called "Genetic Pressure" explores the scientific and moral implications of a world with a burgeoning designer baby industry.
  • It's currently illegal to implant genetically edited human embryos in most nations, but designer babies may someday become widespread.
  • While gene-editing technology could help humans eliminate genetic diseases, some in the scientific community fear it may also usher in a new era of eugenics.
Keep reading Show less

Designer uses AI to bring 54 Roman emperors to life

It's hard to stop looking back and forth between these faces and the busts they came from.

Meet Emperors Augustus, left, and Maximinus Thrax, right

Credit: Daniel Voshart
Technology & Innovation
  • A quarantine project gone wild produces the possibly realistic faces of ancient Roman rulers.
  • A designer worked with a machine learning app to produce the images.
  • It's impossible to know if they're accurate, but they sure look plausible.
Keep reading Show less

Archaeologists identify contents of ancient Mayan drug containers

Scientists use new methods to discover what's inside drug containers used by ancient Mayan people.

A Muna-type paneled flask with distinctive serrated-edge decoration from AD 750-900.

Credit: WSU
Surprising Science
  • Archaeologists used new methods to identify contents of Mayan drug containers.
  • They were able to discover a non-tobacco plant that was mixed in by the smoking Mayans.
  • The approach promises to open up new frontiers in the knowledge of substances ancient people consumed.
Keep reading Show less

Ten “keys to reality” from a Nobel-winning physicist

To understand ourselves and our place in the universe, "we should have humility but also self-respect," Frank Wilczek writes in a new book.

Photo by Andy HYD on Unsplash
Surprising Science
In the spring of 1970, colleges across the country erupted with student protests in response to the Vietnam War and the National Guard's shooting of student demonstrators at Kent State University.
Keep reading Show less
Mind & Brain

This is your brain on political arguments

Debating is cognitively taxing but also important for the health of a democracy—provided it's face-to-face.

Scroll down to load more…
Quantcast